Sarepta Therapeutics Inc
SRPT
NASDAQ
Biotechnology
$18.10
USD
-0.32 (-1.74%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.94B
Volume 1.6M
Price Target
$27.00 – $27.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $27.00 and a min estimate of $27.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$27.00
+$2.2 vs prior
Implied Upside
+49.2%
+12.1% vs prior
Analyst Covering
1
-4 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
17%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Andy Chen | Wolfe Research | Buy | Upgraded | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
RXRX
Recursion Pharmaceuticals Inc
$3.16
▼ -4.5%
AGIO
Agios Pharmaceuticals Inc
$33.56
▲ +0.3%
DMRA
Damora Therapeutics Inc
$31.04
▲ +1.0%
STOK
Stoke Therapeutics Inc
$31.27
▼ -0.1%
TSHA
Taysha Gene Therapies Inc
$5.95
▼ -0.7%
ANAB
AnaptysBio Inc
$58.47
▲ +4.4%
NTLA
Intellia Therapeutics Inc
$11.91
▲ +0.7%
SNDX
Syndax Pharmaceuticals Inc
$19.84
▲ +4.0%
GENB
Generate Biomedicines Inc
$15.64
▲ +4.1%